These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7635916)

  • 21. The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment.
    Florence E; Dreezen C; Schrooten W; Van Esbroeck M; Kestens L; Fransen K; De Roo A; Colebunders R
    Int J STD AIDS; 2004 Aug; 15(8):538-42. PubMed ID: 15307965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients].
    Hodara VL; Monticelli A; Benetucci J; Lasala M; Jauregui Rueda H; Libonatti O; García Messina O; Reboredo G; Bogdanowicz E; Bases O; Pampuro S; Salomón H
    Rev Argent Microbiol; 1998; 30(1):1-7. PubMed ID: 9629601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of HIV-1 viral load in pregnancy.
    Lillo FB; Bucceri AM; Bettini P; Farma E; Boeri E; Mastrorilli E; Rossi G; Vignali M; Varnier OE
    AIDS; 1997 Sep; 11(11):1397-8. PubMed ID: 9302452
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing HIV. Part 4: Primary therapy. 4.3 The laboratory in managing HIV infection.
    Dwyer DE; Adelstein S; Cunningham AL; Merigan TC
    Med J Aust; 1996 Mar; 164(5):301-3. PubMed ID: 8628167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New biological monitoring of HIV infection].
    Morand-Joubert L
    Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection.
    Nadal D; Böni J; Kind C; Varnier OE; Steiner F; Tomasik Z; Schüpbach J
    J Infect Dis; 1999 Oct; 180(4):1089-95. PubMed ID: 10479135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of CD4+ T cells, HIV disease stage and zidovudine on HIV isolation in Bahia, Brazil.
    Brites C; Pedroso C; Silva N; Johnson WD; Badaró R
    Rev Soc Bras Med Trop; 1996; 29(1):5-9. PubMed ID: 8851208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring viral load in the clinical setting.
    Harrigan R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S34-40. PubMed ID: 8595506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus.
    Cheeseman SH; Havlir D; McLaughlin MM; Greenough TC; Sullivan JL; Hall D; Hattox SE; Spector SA; Stein DS; Myers M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):141-51. PubMed ID: 7530585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory markers associated with progression of HIV infection.
    Kiepiela P; Smith AN; Rosenberg E
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):243-54. PubMed ID: 15778113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization.
    Kran AM; Sommerfelt MA; Sørensen B; Nyhus J; Baksaas I; Bruun JN; Kvale D
    Vaccine; 2005 Jul; 23(31):4011-5. PubMed ID: 15963359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs.
    Schooley RT
    AIDS; 1995 Dec; 9 Suppl 2():S15-S19. PubMed ID: 8775802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia.
    Bush CE; Donovan RM; Markowitz N; Baxa D; Kvale P; Saravolatz LD
    J Clin Microbiol; 1996 Apr; 34(4):970-2. PubMed ID: 8815119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach to antiretroviral treatment of HIV disease. Combined antiretroviral therapy: the emerging role.
    Deeks S; Volberding P
    Hosp Pract (1995); 1995 Aug; 30 Suppl 1():23-31. PubMed ID: 7635914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral combination therapy and HIV infection. Such treatment improved CD4 counts in Scottish patients.
    McMenamin J; Allardice G; Goldberg D; Parpia T; Raab G
    BMJ; 1998 Sep; 317(7162):887. PubMed ID: 9748196
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials.
    Flexner C; van der Horst C; Jacobson MA; Powderly W; Duncanson F; Ganes D; Barditch-Crovo PA; Petty BG; Baron PA; Armstrong D
    J Infect Dis; 1994 Dec; 170(6):1394-403. PubMed ID: 7995977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of surrogate markers in evaluation of antiviral therapy for HIV infection.
    Deyton L
    JAMA; 1996 Jul; 276(2):159-60. PubMed ID: 8656509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.